Find your next paid study

john eisenbreyNCT06261814

~$10 – $7,500

Phase 2

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety o…

Non-Alcoholic Fatty Liver Disease

~$10 – $7,500

Justin RyderNCT06355310

Hepatic EncephalopathyLiver CirrhosisPortal Shunt Systemic

Endoscopic Ultrasound Embolization of Porto-Systemic Shunt for Management of Medically Refractory Hepatic Encephalopathy: A Randomized Trial

The goal of this clinical trial is to learn if endoscopic ultrasound guided (EUS guided) spontaneous porto-systemic shunt (SPSS) embolization works to treat re…

Rutgers, The State University of New JerseyNCT07553858

Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.

Liver

M.D. Anderson Cancer CenterNCT05879159

Fatty LiverHepatic Steatosis

Siemens Biomarker Multi-modality

The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compare…

Duke UniversityNCT07495332

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressi…

Non-Alcoholic Fatty Liver Disease

AdventHealth Translational Research InstituteNCT04807868

~$10 – $1,125

End Stage Renal DiseaseEnd Stage Liver Disease

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media an…

Johns Hopkins UniversityNCT03803423

Phase 2

Phase II Single Arm Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis (STRIDE in CP-B)

This is a single-arm, phase II study of patients with advanced liver cancer or hepatocellular carcinoma (HCC) who are eligible for first-line treatment with T3…

Hepatocellular CarcinomaCirrhosis, Liver

The University of Texas Health Science Center at San AntonioNCT06526104

Phase 4

A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia

The reported risk of nonreassuring fetal heart trace following neuraxial analgesia is 3-23%. This variability may be due to fluid and oxytocin management prior…

Fetal Bradycardia Complicating Labor and DeliveryFetal Bradycardia During LaborFetal Heart Rate or Rhythm Abnormality Affecting Fetus

~$10 – $7,500

Unyime ItukNCT03232918

CVD - Cardiovascular DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Pilot Test of Su Corazon Su Vida Among Mexican Origin Adults With MASLD

CVD is the leading cause of death among individuals with MASLD, a risk factor for liver cancer. In Southern Arizona, CVD and cancer (including liver and gastri…

University of ArizonaNCT07298213

Liver Transplant; ComplicationsPediatric ALL

HEalth Advocate for Liver Transplant - Pilot

The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess fe…